CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.

[1]  A. Bosio,et al.  Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. , 2008, The Journal of investigative dermatology.

[2]  D. Askew,et al.  Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. , 2007, The Journal of investigative dermatology.

[3]  T. Bieber,et al.  Type I interferon‐associated cytotoxic inflammation in lichen planus , 2006, Journal of cutaneous pathology.

[4]  R. Bronson,et al.  Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  T. Bieber,et al.  Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin‐homing cytotoxic lymphocytes associated with strong expression of the type I interferon‐induced protein MxA , 2005, The British journal of dermatology.

[6]  T. Bieber,et al.  Evidence for a role of type I interferons in the pathogenesis of dermatomyositis , 2005, The British journal of dermatology.

[7]  P. V. D. van de Kerkhof,et al.  Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T‐cell subsets, epidermal proliferation and differentiation , 2005, The British journal of dermatology.

[8]  A. Zlotnik,et al.  Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. , 2005, Arthritis and rheumatism.

[9]  J. Clot,et al.  The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon‐α treatment , 2005, The British journal of dermatology.

[10]  T. Bieber,et al.  Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus , 2005, The Journal of pathology.

[11]  D. Jain,et al.  Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. , 2004, Blood.

[12]  S. Clouthier,et al.  Role of CXCR3-induced donor T-cell migration in acute GVHD. , 2003, Experimental hematology.

[13]  M. Fimiani,et al.  Chronic graft versus host disease and skin , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  C. Anasetti,et al.  Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. , 2003, Transplant immunology.

[15]  A. Lewis-Antes,et al.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. , 2003, Nature immunology.

[16]  G. Kochs,et al.  Interferon‐Induced Mx Proteins: Dynamin‐Like GTPases with Antiviral Activity , 2002, Traffic.

[17]  A. Román,et al.  Atypical chronic graft-versus-host disease following interferon therapy for chronic myeloid leukaemia relapsing after allogeneic BMT , 2001, Bone Marrow Transplantation.

[18]  P. Sugerman,et al.  Autocytotoxic T‐cell clones in lichen planus , 2000, The British journal of dermatology.

[19]  García‐Buey,et al.  Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon‐α , 1998 .

[20]  C. García-Monzón,et al.  Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha. , 1998, Alimentary pharmacology & therapeutics.

[21]  R. Kamen,et al.  Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production , 1997, Nature.

[22]  R. Kamen,et al.  Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. , 1997, Nature.

[23]  R. Dorr.  Interferon-alpha in malignant and viral diseases. A review. , 1993, Drugs.

[24]  M. Horisberger.  Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins , 1992, Journal of virology.

[25]  D. Reece,et al.  Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected] [published erratum appears in Blood 1992 Jun 15;79(12):3397] , 1991 .

[26]  D. Reece,et al.  Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]. , 1991, Blood.